Skip to content

The effect of a superficial parasternal intercostal plane block in cardiac surgical patients undergoing conventional median sternotomy: a multicentric, double-blind, prospective, randomized controlled superiority trial.

Status
Recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-522135-34-00
Enrollment
136
Registered
2025-10-01
Start date
2025-11-14
Completion date
Unknown
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing cardiac surgery through conventional median sternotomy access

Brief summary

The primary outcome is the mean difference in QoR-15NL score between the verum bilateral SPIP block (intervention group) and the placebo bilateral SPIP block (control group) in patients undergoing cardiac surgery via conventional median sternotomy on the first postsurgical day, defined as 24 hours after surgical incision, assessed by the Dutch Quality of Recovery 15 items questionnaire.

Detailed description

The cumulative opioid consumption in the first 72 hours after surgical incision, Time to first rescue analgesia for breakthrough pain (e.g. oxycodone or piritramide) in the first 72 hours after surgical incision (in minutes)., The AUC of the reported dynamic NRS scores at predefined timepoints (assessed at 3, 6, 12, 24, 48, 72 hours) during the first 72 hours after surgical incision., The AUC of the reported dynamic NRS scores at predefined timepoints (assessed at 3, 6, 12, 24, 48, 72 hours) during the first 72 hours after surgical incision., Number of patients with PONV in the first 24 hours after surgical incision, Time spent in the ICU/PACU until fit for discharge (in hours)., Time spent in the hospital between surgical incision and the first hospital discharge (in hours)., Occurrence of respiratory complications, leading to non-invasive ventilation (NIV) or high-flow nasal cannula (HFNC) oxygen therapy, orotracheal intubation for more than 24 hours or orotracheal re-intubation, QoR-15NL score on the second (D2) after surgery, EQ-5D-5L score 30 days after surgery

Interventions

DRUG9 %
DRUGoplossing voor injectie
DRUGNaropin® 7
DRUG5 mg/ml Amp. 20 ml Injektionslösung

Sponsors

UZ Leuven
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The primary outcome is the mean difference in QoR-15NL score between the verum bilateral SPIP block (intervention group) and the placebo bilateral SPIP block (control group) in patients undergoing cardiac surgery via conventional median sternotomy on the first postsurgical day, defined as 24 hours after surgical incision, assessed by the Dutch Quality of Recovery 15 items questionnaire.

Secondary

MeasureTime frame
The cumulative opioid consumption in the first 72 hours after surgical incision, Time to first rescue analgesia for breakthrough pain (e.g. oxycodone or piritramide) in the first 72 hours after surgical incision (in minutes)., The AUC of the reported dynamic NRS scores at predefined timepoints (assessed at 3, 6, 12, 24, 48, 72 hours) during the first 72 hours after surgical incision., The AUC of the reported dynamic NRS scores at predefined timepoints (assessed at 3, 6, 12, 24, 48, 72 hours) during the first 72 hours after surgical incision., Number of patients with PONV in the first 24 hours after surgical incision, Time spent in the ICU/PACU until fit for discharge (in hours)., Time spent in the hospital between surgical incision and the first hospital discharge (in hours)., Occurrence of respiratory complications, leading to non-invasive ventilation (NIV) or high-flow nasal cannula (HFNC) oxygen therapy, orotracheal intubation for more than 24 hours or orotracheal re-intubation, Qo

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026